Thomas N. Chase, M.D.

Affiliations: 
National Institutes of Health, Bethesda, MD 
Area:
Parkinson's disease
Google:
"Thomas Chase"
Mean distance: 18.7 (cluster 11)
 
Cross-listing: Neuropathology Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Vanover KE, Betz AJ, Weber SM, et al. (2008) A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model. Pharmacology, Biochemistry, and Behavior. 90: 540-4
Liang ZQ, Wang X, Li LY, et al. (2007) Nuclear factor-kappaB-dependent cyclin D1 induction and DNA replication associated with N-methyl-D-aspartate receptor-mediated apoptosis in rat striatum. Journal of Neuroscience Research. 85: 1295-309
Liang ZQ, Li YL, Zhao XL, et al. (2007) NF-kappaB contributes to 6-hydroxydopamine-induced apoptosis of nigral dopaminergic neurons through p53. Brain Research. 1145: 190-203
Smith CP, Oh JD, Bibbiani F, et al. (2007) Tamoxifen effect on L-DOPA induced response complications in parkinsonian rats and primates. Neuropharmacology. 52: 515-26
Bara-Jimenez W, Dimitrova TD, Sherzai A, et al. (2006) Glutamate release inhibition ineffective in levodopa-induced motor complications. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1380-3
Andringa G, Bol JG, Wang X, et al. (2006) Changed distribution pattern of the constitutive rather than the inducible HSP70 chaperone in neuromelanin-containing neurones of the Parkinsonian midbrain. Neuropathology and Applied Neurobiology. 32: 157-69
Bibbiani F, Oh JD, Kielaite A, et al. (2005) Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD. Experimental Neurology. 196: 422-9
Liang ZQ, Wang XX, Wang Y, et al. (2005) Susceptibility of striatal neurons to excitotoxic injury correlates with basal levels of Bcl-2 and the induction of P53 and c-Myc immunoreactivity. Neurobiology of Disease. 20: 562-73
Bara-Jimenez W, Bibbiani F, Morris MJ, et al. (2005) Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 932-6
Zhang HL, Huang ZH, Zhu Y, et al. (2005) Neuroprotective effects of prostaglandin A1 in animal models of focal ischemia. Brain Research. 1039: 203-6
See more...